Conference Coverage

Rivaroxaban no help for heart failure outcomes


 

SOURCE: Zannad F et al. NEJM/ESC.

.

Pages

Recommended Reading

Galectin-3: A new post-MI prognostic biomarker?
MDedge Internal Medicine
Heart failure confers poor prognosis in rheumatoid arthritis
MDedge Internal Medicine
ICD use curbed in hospitals named in federal lawsuit
MDedge Internal Medicine
Medicare’s bundled pay plan didn’t deliver big cost savings
MDedge Internal Medicine
Ten tips for managing patients with both heart failure and COPD
MDedge Internal Medicine
Incident heart failure linked to HIV infection
MDedge Internal Medicine
FDA: Cancer risk low with recalled valsartan
MDedge Internal Medicine
More female authors than ever in cardiology journals
MDedge Internal Medicine
Prolonged antimalarial therapy linked to elevated cardiac biomarkers, cardiomyopathy
MDedge Internal Medicine
AHA: Chagas disease and its heart effects have come to the U.S.
MDedge Internal Medicine